Great West Life Assurance CO Crinetics Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 17,339 shares of CRNX stock, worth $960,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,339
Previous 17,339
-0.0%
Holding current value
$960,060
Previous $776,000
14.3%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CRNX
# of Institutions
242Shares Held
79.6MCall Options Held
23.3KPut Options Held
44.3K-
Vanguard Group Inc Valley Forge, PA6.29MShares$348 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$345 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.89MShares$326 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$274 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA4.46MShares$247 Million0.04% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.98B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...